Diovan

Rediff.com » News » Diovan

News for Diovan

Business

Ranbaxy gets FDA nod to sell generic Diovan tablets in US

Drug major Ranbaxy Laboratories has received US health regulator's approval to market generic version of Novartis' Diovan tablets, used for treating high blood pressure and heart failure, in the US......

Why Sun Pharma stock will remain under pressure

The weakness in the stock was because of inspections by the American drug regulator at its Halol plant in Gujarat which resulted in eight observations, as well as a downward revision of speciality......

Ranbaxy may get approval for multi-billion dollar drug

The long-awaited US approval for Ranbaxy Laboratories' generic version of anti-hypertension drug Diovan is likely to come this week, according to industry sources.While this could pull the company......

A Mylan win in US court could hit Ranbaxy

Ranbaxy Laboratories Ltd might lose the 180-day opportunity to exclusively sell its generic version of Novartis AG's hypertension drug Diovan if a US district court rules in favour of Mylan, which......

Sensex ends flat amid choppy trade; Nifty above 7,500

Benchmark indices ended flat, amid a choppy trading session, as investors turned cautious on concerns that the weak monsoon would further accelerate inflation while the continuing crisis in Iraq......

Rediff News

Diovan

News for Diovan

Ranbaxy gets FDA nod to sell generic Diovan tablets in US

Why Sun Pharma stock will remain under pressure

Ranbaxy may get approval for multi-billion dollar drug

A Mylan win in US court could hit Ranbaxy

Sensex ends flat amid choppy trade; Nifty above 7,500

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS